Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

PDI Identifies 40 Potential Products For Sales Through LifeCycle X-Tension

Executive Summary

Professional Detailing, Inc. has identified 40 products that could be marketed through its LifeCycle X-Tension service, CEO Charles Saldarini said.

You may also be interested in...



PDI/Bayer Detailing Focuses On Cipro, Avelox After Baycol Withdrawal

PDI and Bayer are discussing which product will replace Bayer's withdrawn cholesterol-lowering agent Baycol in their contract sales agreement

PDI/Bayer Detailing Focuses On Cipro, Avelox After Baycol Withdrawal

PDI and Bayer are discussing which product will replace Bayer's withdrawn cholesterol-lowering agent Baycol in their contract sales agreement

PDI's Ceftin Primary Care Sales Force Could Transition To Another Product

Professional Detailing, Inc. expects to transition its Ceftin sales force to another product after it ceases primary care promotion of the GlaxoSmithKline antibiotic.

Related Content

Latest Headlines
See All
UsernamePublicRestriction

Register

PS038372

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel